| Literature DB >> 30356315 |
Olivia Svolgaard1, Kasper Winther Andersen1, Christian Bauer1,2, Kristoffer Hougaard Madsen1,3, Morten Blinkenberg4, Finn Selleberg4, Hartwig Roman Siebner1,5.
Abstract
Fatigue is a common and highly disabling symptom of multiple sclerosis. Patients experience an effort-independent general subjective feeling of fatigue as well as excessive fatigability when engaging in physical or mental activity. Previous research using functional magnetic resonance imaging (fMRI) has revealed heterogeneous findings, but some evidence implicates the motor system. To identify brain correlates of fatigue, 44 mildly impaired patients with relapsing-remitting multiple sclerosis and 25 age- and gender-matched healthy controls underwent functional magnetic resonance imaging at 3 Tesla, while they performed alternating blocks of rest and a non-fatiguing precision grip task. We investigated neural correlates of fatigue using the motor subscore of Fatigue Scale for Motor and Cognitive Functions (FSMCMOTOR) using the bilateral motor cerebellum, putamen, and dorsal premotor cortex as regions of interest. Patients and healthy controls performed the grip force task equally well without being fatigued. In patients, task-related activity in lobule VI of right motor cerebellum changed in proportion with individual FSMCMOTOR scores. In right dorsal premotor cortex, linear increases in activity across consecutive task blocks scaled with individual FSMCMOTOR scores in healthy controls, but not in patients. In premotor and dorsomedial prefrontal areas, patients were impaired at upscaling task-related activity the more they were affected by motor fatigue. The results support the notion that increased sensorimotor processing in the cerebellum contributes to the experience of motor fatigue and fatigability in multiple sclerosis. Additionally, downscaling of motivational input or sensorimotor processing in prefrontal and premotor areas may constitute an additional pathophysiological factor.Entities:
Mesh:
Year: 2018 PMID: 30356315 PMCID: PMC6200185 DOI: 10.1371/journal.pone.0201162
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The precision grip task and parametric modulation.
(A) The tonic precision grip task consisted of 12 task blocks (each 20 s) alternated by periods of rest (20 s). During the grip task, visual feedback of the exerted grip force (blue area) and the required target force (grey circle) was continuously provided. (B) Participants had to maintain a target force corresponding to 20% of the individual maximal voluntary contraction and the grip force output was continuously recorded. (C) Task-related activity was analysed using a General Linear Model in which the constant main effect of task (main effect) as well as linear modulation of task-related activity (linear time effect) were modelled. Task-related activation during the first block (red line) was separately modelled and treated as effect of no interest.
Fig 2The mask used to define the region of interest.
A single mask consisting of the cerebellum lobule VI, putamen, and PMd of both hemispheres were used to define the region of interest.
Clinical characteristics of MS patients and healthy controls.
| MS n = 44 | HC n = 25 | ||||||
|---|---|---|---|---|---|---|---|
| Mean | Range | SD | Mean | Range | SD | p | |
| Age | 35.9 | (22–53) | 8.8 | 35.8 | (19–55) | 10.6 | .979 |
| Gender (M:F) | 14:30 | 32%:68% | 9:16 | 36%:64% | .723 | ||
| Median EDSS | 2.5 | (0–3.5) | 1.0 | ||||
| Disease duration | 6.3 | (0–28) | 5.2 | ||||
| Treatment | 40 MS | 90.9% | |||||
| FSMC TOTAL | 59.3 | (20–92) | 21.3 | 28.0 | (20–46) | 8.2 | .000 |
| FSMC MOTOR | 28.8 | (10–45) | 10.6 | 12.9 | (10–23) | 3.2 | .000 |
| FSMC COGNITIVE | 30.5 | (10–48) | 11.9 | 15.0 | (10–28) | 5.6 | .000 |
| BDI—II | 7.2 | (0–22) | 6.0 | 1.6 | (0–11) | 2.8 | .000 |
| PSQI | 5.2 | (1–18) | 3.7 | 3.4 | (1–5) | 1.4 | .005 |
| ESS | 8.2 | (2–17) | 3.9 | 6.4 | (0–14) | 4.0 | .080 |
| PASAT | 50.1 | (33–60) | 7.5 | 51.1 | (43–59) | 5.0 | .506 |
| SDMT | 54.2 | (35–89) | 10.5 | 56.5 | (41–70) | 6.7 | .280 |
| JTHFT RIGHT HAND | 37.7 | (30–53) | 4.2 | 35.4 | (29–41) | 3.5 | .026 |
| 9-HPT RIGHT HAND | 15.9 | (13–24) | 2.0 | 15.7 | (13–19) | 1.8 | .628 |
| Mean TIV | 1561.3 | 141.4 | 1594.9 | 154.7 | .362 | ||
| Mean WM | 482.7 | 59.9 | 500.2 | 56.9 | .135 | ||
| Mean GMV | 637.5 | 47.9 | 657.2 | 47.9 | .170 | ||
| Mean WMHV | 5.9 | (0.3–30.7) | 6.5 | ||||
* = p–value < 0.05
Abbreviations: Age = Age in years, BDI—II = Beck depression inventory version II, Disease duration = Years since diagnose, EDSS = Expanded disability status score, ESS = Epworth sleepiness scale, FMS = MS patients with fatigue, FSMCCOGNITIVE = FSMC cognitive score, FSMCMOTOR = FSMC motor score, FSMCTOTAL = Fatigue scale for motor and cognitive functions total score, Gender (M : F) = Male: female ratio, HC = Healthy controls, GMV = Grey matter volume in millilitre, JTHFT = Jebsen-Taylor hand function test, MS = Multiple sclerosis, NFMS = MS patients without fatigue, WMHV = White matter hyperintensities volume (i.e. white matter lesions, in millilitre), 9-HPT = Nine hole peg test, p = P–value, PASAT = Paced auditory serial addition test, PSQI = Pittsburgh sleep quality index, SD = Standard deviation, SDMT = Symbol digit modalities test, TIV = Total intracranial (volume in millilitre), Treatment = In treatment with multiple sclerosis disease modifying drugs, WMV = White matter volume in millilitre.
Clinical characteristics of the MS patients.
| NFMS n = 17 | FMS | ||||||
|---|---|---|---|---|---|---|---|
| Mean | Range | SD | Mean | Range | SD | p | |
| Age | 34.5 | (22–50) | 8.3 | 36.7 | (25–53) | 9.7 | .411 |
| Gender (M : F) | 8:9 | 47%:53% | 6:21 | 22%:78% | .085 | ||
| Median EDSS | 2.0 | (0–3.5) | 1.1 | 2.5 | (0–3.5) | 0.8 | .023 |
| Disease duration | 6.4 | (1–28) | 6.4 | 6.2 | (0–16) | 4.5 | .891 |
| Treatment | 15 MS | 88.2% | 25 MS | 92.6% | .624 | ||
| FSMC TOTAL | 38.3 | (20–57) | 14.3 | 72.5 | (45–92) | 12.5 | .000 |
| FSMC MOTOR | 17.4 | (10–25) | 5.5 | 35.9 | (27–45) | 5.4 | .000 |
| FSMC COGNITIVE | 20.9 | (10–42) | 9.6 | 36.6 | (15–48) | 8.9 | .000 |
| BDI—II | 3.4 | (0–10) | 3.3 | 9.7 | (0–22) | 6.2 | .000 |
| PSQI | 4.4 | (2–9) | 1.7 | 5.7 | (1–18) | 4.5 | .171 |
| ESS | 6.8 | (2–17) | 4.3 | 9.0 | (3–17) | 3.5 | .062 |
| PASAT | 52.2 | (41–60) | 5.3 | 48.8 | (33–60) | 8.4 | .102 |
| SDMT | 55.4 | (40–89) | 12.3 | 53.5 | (35–71) | 9.3 | .557 |
| JTHFT RIGHT HAND | 37.3 | (13–22) | 2.4 | 37.9 | (13–24) | 5.1 | .648 |
| 9-HPT RIGHT HAND | 16.0 | (32–40) | 2.0 | 15.9 | (30–53) | 2.1 | .954 |
| Mean TIV | 1620.4 | 147.4 | 1524 | 126.3 | .026 | ||
| Mean WM | 496.7 | 69.2 | 473.8 | 52.7 | .262 | ||
| Mean GMV | 656.2 | 42.8 | 625.7 | 47.9 | .038 | ||
| Mean WMHV | 6.9 | (0.5–30.7) | 7.8 | 5.3 | (0.3–22.9) | 5.5 | .420 |
* = p–value < 0.05
Abbreviations: Age = Age in years, BDI—II = Beck depression inventory version II, Disease duration = Years since diagnose, EDSS = Expanded disability status score, ESS = Epworth sleepiness scale, FMS = MS patients with fatigue, FSMCCOGNITIVE = FSMC cognitive score, FSMCMOTOR = FSMC motor score, FSMCTOTAL = Fatigue scale for motor and cognitive functions total score, Gender (M : F) = Male: female ratio, HC = Healthy controls, GMV = Grey matter volume in millilitre, JTHFT = Jebsen-Taylor hand function test, MS = Multiple sclerosis, NFMS = MS patients without fatigue, WMHV = White matter hyperintensities volume (i.e. white matter lesions, in millilitre), 9-HPT = Nine hole peg test, p = P–value, PASAT = Paced auditory serial addition test, PSQI = Pittsburgh sleep quality index, SD = Standard deviation, SDMT = Symbol digit modalities test, TIV = Total intracranial (volume in millilitre), Treatment = In treatment with multiple sclerosis disease modifying drugs, WMV = White matter volume in millilitre.
Fig 3Main effect of the precision grip task.
T-score maps showing the brain activation during the tonic precision grip task in healthy controls and patients with MS. For visualisation purposes, the maps were thresholded at an uncorrected p-value of < 0.001.
Group results of the fMRI data.
| Peak | MNI- | P value | Cluster size | |||||
|---|---|---|---|---|---|---|---|---|
| Contrast | Region | Side | T value | x | y | z | ||
| Cerebellum VI | R | 4.68 | 30 | -44 | -24 | 0.046 (SVC) | 35 | |
| STG | R | 5.98 | 48 | -34 | 20 | 0.004 | 123 | |
| PMd | L | 6.27 | -30 | 4 | 46 | 0.017 | 87 | |
| PMd | L | 4.75 | -26 | -12 | 74 | 0.049 (SVC) | 39 | |
| dmPFC | L | 5.96 | -12 | 38 | 54 | 0.038 | 70 | |
| Cerebellum VI | L | 4.75 | -34 | -46 | -32 | 0.042 (SVC) | 30 | |
| PCC | R/L | 5.62 | 2 | -44 | 10 | 0.018 | 685 | |
| Lingual gyrus | ||||||||
| PMd | R | 4.60 | 22 | -12 | 78 | 0.031 (SVC) | 31 | |
| Cerebellum | L | 4.57 | -16 | -58 | -12 | 0.034 (SVC) | 11 | |
| Lingual gyrus | L | 7.17 | -16 | -54 | -10 | 0.000 | 185 | |
Group results of the fMRI data. T-values and p-values refer to the voxel showing peak difference in a given cluster. Cluster extent is defined by an uncorrected cluster-forming extent threshold of p < 0.001. The p-values reflect significant activity changes at peak-voxel level (p-value < 0.05) after whole-brain FWE correction for multiple comparisons. SVC = small volume correction: For voxels within the a priori defined ROIs, FWE correction only considered the voxels within the mask comprising all pre-defined ROIs. As for the whole-brain analysis, the FWE method was applied at the peak-voxel level. Only voxels with a FWE corrected p-value < 0.05 were considered to be significant. Cerebellum VI = Cerebellum lobe VI. dmPFC = Dorsomedial prefrontal cortex. FMS = Fatigued MS patients. FSMCMOTOR = Fatigue Scale for Motor and Cognitive Functions, motor subscale. HC = Healthy controls. MS = Multiple sclerosis. NFMS = non-fatigued MS patients. PCC = Posterior cingulate cortex. PMd = Dorsal premotor cortex. STG = Superior temporal gyrus.
Fig 4MS patients—within group analysis.
Linear scaling of the constant task-related activation during a non-fatiguing grip force task, with the amount of experienced fatigue during daily life, as indexed by the FSMCMOTOR score. In right motor cerebellum there was a linear increase in task-related activation in the MS group with increasing motor fatigue (pSVC = 0.046, r2 = 0.36).
Fig 5The non-fatigued MS patients compared to the fatigued MS patients.
Linear scaling of the constant task-related activation during a non-fatiguing grip force task, with the amount of experienced fatigue during daily life, as indexed by the FSMCMOTOR scores in the non-fatigued MS patients compared to the fatigued MS patents.(A) The left ventral part of the dorsal premotor cortex (PMd) (pFWE = 0.017), (B) left caudal part of the dorsal premotor cortex (PMd) (pSVC = 0.049) and (C) left dorsomedial prefrontal cortex (dMPFC) showed increased linear correlation between task-related activation and FSMCMOTOR scores in the non-fatigued MS patients (blue) compared with the fatigued MS patients (red) (pFWE = 0.038).
Fig 6MS patients compared to healthy controls.
MS patients’ task-related activity scaled with individual FSMCMOTOR scores relatively to the scaling in healthy controls. Healthy controls showed a stronger time-dependent increase in task-related activity in the right dorsal premotor cortex (PMd) than patients with MS (pSVC = 0.031). In healthy controls, the linear time modulation of task scaled with the individual FSMCMOTOR scores (blue). The more controls experienced fatigue during daily life; the more they displayed a linear increase in task-related activity with time during the non-fatiguing grip force task. This relationship was not present in MS patients (red).